There are forces at work in heart and vascular medicine that may tear practitioners apart or bring them together. Changes in technology and training have created serious competition for patients and discord among physicians in medical centers across the country.
The UCSF Pulmonary Hypertension Program has been designated a center of excellence for the evaluation and treatment of the disorder. Recent research has produced a number of useful therapies and rapid progress in basic research is pointing to promising therapeutic strategies.
Despite the very widespread and sometimes serious nature of venous disorders, they are not aggressively diagnosed or treated. The UCSF venous center has been growing rapidly, addressing the dearth of care through rapid diagnosis and treatment plans tailored to special-needs patients.
UCSF interventional cardiologist and researcher Yerem Yeghiazarians, M.D., hopes that stem cells may offer a way to repair damage to the heart that results from heart attack.
UCSF cardiac surgeon Scot Merrick, M.D., regularly sees the benefit of performing mitral valve repair early, before the appearance of gross symptoms such as orthopnea or cough becomes manifest.
Traditionally, significant kidney disease has been a contraindication for heart transplantation. Transplant cardiologists and surgeons at UCSF are aggressively taking an alternative approach by performing simultaneous heart and kidney transplantation. In the process, they are helping those who did not seem to have much hope of ever getting a new heart.
See information on upcoming continuing medical education courses.
The UCSF Transfer Center is open 24 hours daily to coordinate the transfer of your patients to UCSF Medical Center from hospitals throughout the region.
Phone: (415) 353-9166
Fax: (415) 353-9172